Wall Street Associates’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.14M Sell
274,770
-311,430
-53% -$1.52M 0.75% 47
2016
Q3
$3.49M Buy
586,200
+20,000
+4% +$101K 1.19% 12
2016
Q2
$2.81M Buy
566,200
+126,774
+29% +$555K 1.13% 21
2016
Q1
$1.98M Buy
439,426
+137,300
+45% +$623K 0.82% 43
2015
Q4
$1.83M Buy
302,126
+6,400
+2% +$44.3K 0.52% 67
2015
Q3
$2.22M Buy
+295,726
New +$2.15M 0.42% 75

Other funds holding ASPN

Wall Street Associates's ASPN Position: Q4 2016 in Review

Wall Street Associates reduced its Aspen Aerogels (ASPN) stake by 53% in Q4 2016, selling an estimated $1.52M and leaving 274,770 shares worth $1.14M. The position accounts for 0.75% of the portfolio, ranked #47.

Wall Street Associates first reported a position in ASPN in Q3 2015 and has held it in 6 quarters since. The position peaked at $3.49M in Q3 2016. 54 funds tracked by Wall St. Rank hold ASPN as of Q4 2016.

  • Wall Street Associates held 274,770 shares of Aspen Aerogels worth $1.14M as of Q4 2016.
  • Wall Street Associates sold 311,430 Aspen Aerogels shares in Q4 2016, an estimated $1.52M.
  • Aspen Aerogels made up 0.75% of Wall Street Associates's portfolio in Q4 2016, its #47 holding.
  • Wall Street Associates first reported a position in Aspen Aerogels in Q3 2015 and has held it in 6 quarters since.
  • Wall Street Associates's Aspen Aerogels position peaked at $3.49M in Q3 2016.
  • 54 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2016.

Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.